VitaNova Life Sciences (YJGJ) Invested Capital (2017 - 2026)
VitaNova Life Sciences (YJGJ) has disclosed Invested Capital for 9 consecutive years, with $1.9 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Invested Capital rose 63.23% year-over-year to $1.9 million, compared with a TTM value of $1.9 million through Oct 2025, up 63.23%, and an annual FY2025 reading of $1.9 million, up 80.25% over the prior year.
- Invested Capital was $1.9 million for Q4 2025 at VitaNova Life Sciences, up from $1.9 million in the prior quarter.
- Across five years, Invested Capital topped out at $1.9 million in Q2 2025 and bottomed at -$83462.0 in Q3 2023.
- Average Invested Capital over 5 years is $535241.2, with a median of -$3999.0 recorded in 2021.
- The sharpest move saw Invested Capital tumbled 1088.26% in 2023, then surged 2556.08% in 2024.
- Year by year, Invested Capital stood at -$4998.0 in 2021, then plummeted by 263.21% to -$18153.0 in 2022, then crashed by 318.55% to -$75980.0 in 2023, then surged by 1630.5% to $1.2 million in 2024, then skyrocketed by 63.23% to $1.9 million in 2025.
- Business Quant data shows Invested Capital for YJGJ at $1.9 million in Q4 2025, $1.9 million in Q3 2025, and $1.9 million in Q2 2025.